Landiolol

Sibboran

300 MG / VIAL Powder For SolutionCanadaNot marketedAuthorised 11 Aug 2024

In other countries

The same active substances on other registers, the same brand first.

RapiblykUnited States · 280MG BASE/VIAL · powder · Aop HLTH USSame strength and form
Rapibloc 300 mg prašak za otopinu za infuzijuCroatia · prašak za otopinu za infuziju · Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, AustrijaSame form
Rapibloc 300 MG Polvo Para Solucion Para PerfusionSpain · 300 mg · polvo para solución para perfusión · Orpha-Devel Handels Und Vertriebs GmbhSame substance
Rapibloc 20 mg/2 ml koncentrat za otopinu za injekcijuCroatia · koncentrat za otopinu za injekciju · Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, AustrijaSame substance
LandioblocItaly · Concentrato per soluzione iniettabile · Amomed Pharma GMBHSame substance
Landiolol Hydrochloride Orpha-Devel 300 mg poeder voor oplossing voor infusie

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Landiolol

Sibboran

300 MG / VIAL Powder For SolutionCanadaNot marketedAuthorised 11 Aug 2024

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Netherlands · Poeder voor oplossing voor infusie · Orpha Devel Handels-und Vertriebs GmbH

Rapibloc 20 mg/2 ml concentraat voor oplossing voor injectieNetherlands · Concentraat voor oplossing voor injectie · Amomed Pharma GmbH

Rapibloc 300 mg poeder voor oplossing voor infusieNetherlands · Poeder voor oplossing voor infusie · Amomed Pharma GmbH

RAPIBLOC 300 mgRomania · 300 mg · pulb. pt. sol. perf. · Anomed Pharma GMBH

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Landiolol
Strength: 300 MG / VIAL
Dosage form: Powder For Solution
Route: Intravenous
Register: Canada (Health Canada)
Status: Not marketed
Status in the register: Dormant
Authorised: 11 Aug 2024
Registration: DIN 02543338
Marketing authorisation holder: Aop Orphan Pharmaceuticals GMBH
ATC code: C07AB14
Group: Cardiovascular system
Supply: PRESCRIPTION